Sponsor or institution
Clinical trials and research at Northside Hospital, Inc.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Northside Hospital, Inc. that are recruiting, in United States. By phase: Phase 2 (5). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Early tacrolimus in HLA-mismatched haploidentical blood stem-cell transplant with post-transplant cyclophosphamide | Phase 2 | Atlanta, Georgia | Recruiting | Feb 14, 2025 |
| CAR T-cell therapy for patients with kidney issues | Phase 2 | Atlanta, Georgia | Recruiting | Jun 18, 2023 |
| Preventing neurotoxicity in leukemia treatment with intrathecal chemotherapy | Phase 2 | Atlanta, Georgia | Recruiting | Aug 29, 2022 |
| Reduced intensity transplant protocol for hematologic malignancies | — | Atlanta, Georgia | Recruiting | Jun 14, 2022 |
| Using GM-CSF after transplant to improve recovery from blood cancers | Phase 2 | Atlanta, Georgia | Recruiting | Jan 23, 2020 |
| Haploidentical bone marrow transplant for severe aplastic anemia | Phase 2 | Atlanta, Georgia and 1 other locations | Recruiting | Jul 11, 2016 |
All recruiting trials (6)
-
Early tacrolimus in HLA-mismatched haploidentical blood stem-cell transplant with post-transplant cyclophosphamide
This trial tests whether starting tacrolimus earlier, together with post-transplant cyclophosphamide and mycophenolate, can reduce cytokine release syndrome in people receiving HLA-mismatched haploidentical peripheral blood stem-cell transplants.
-
CAR T-cell therapy for patients with kidney issues
This study is testing if CAR T-cell therapy can be safely given to patients with kidney problems who are getting chemotherapy for blood cancers like multiple myeloma, leukemia, or lymphoma.
-
Preventing neurotoxicity in leukemia treatment with intrathecal chemotherapy
This study is testing if giving a specific chemotherapy directly into the spine can help protect the brain from side effects while treating adults with Acute Lymphoblastic Leukemia.
-
Reduced intensity transplant protocol for hematologic malignancies
This study is testing a gentler transplant method using a specific combination of medications and radiation to see if it helps patients with blood cancers who have a matched donor.
-
Using GM-CSF after transplant to improve recovery from blood cancers
This study is testing if a drug called GM-CSF can help people recovering from blood cancers after a specific type of stem cell transplant to improve their blood cell counts and reduce infection risks.
-
Haploidentical bone marrow transplant for severe aplastic anemia
This study is testing if a special type of bone marrow transplant from a mismatched donor can help people with severe aplastic anemia who don't have a matching donor.
Quick answers
How many clinical trials run by Northside Hospital, Inc. are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.